Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.
Körner
R J
RJ
Department of Medical Microbiology, Southmead Health Services NHS Trust, Westbury-on-Trym, Bristol.
Reeves
D S
DS
MacGowan
A P
AP
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D002939:Ciprofloxacin; D015242:Ofloxacin